When does US Patent 8,602,215 expire?
US Patent No. 8,602,215 is a utility patent, so its scheduled expiration is tied to 20 years from the application’s effective filing date (with possible adjustments for patent term adjustments). The exact expiration date depends on the patent’s listed filing date and any term adjustments shown in the patent record.
However, the specific expiration date for US 8,602,215 is not provided in the information available here, so I can’t confirm the exact day.
What does this have to do with Multaq (dronedarone)?
Multaq is brand-name dronedarone, an antiarrhythmic drug. If you’re asking because you believe this patent covers Multaq (or a formulation/related method of use), the key practical issue is whether the patent is listed in connection with Multaq in the Orange Book for market exclusivity/patent-expiration timing. That listing determines whether the patent is part of the regulatory “patent expiry” landscape for generic or follow-on products.
Without the Orange Book listing details for the specific Multaq NDA and the exact claims coverage, I can’t tie the patent number to a precise Multaq launch/generic entry timeline.
What if the patent doesn’t control the Multaq “expiration date” people talk about?
Drug “expiration dates” in practice usually reflect one (or more) of these:
- Regulatory exclusivity (not patent term) tied to the NDA/505(b)(1) history.
- The NDA-listed patents in the FDA Orange Book (with specific “expires on” dates).
- Patent term adjustments/extending events that change the end date for a given patent.
- Separate patents covering different aspects (drug substance, formulation, methods of use, metabolites, dosing regimens), only some of which block generics.
So even if US 8,602,215 is relevant, the date you care about may be governed by a different listed patent number or by exclusivity rather than that specific patent.
Can you check the exact expiration date quickly?
To get the exact expiration date for US 8,602,215 and confirm whether it blocks Multaq generics, you typically need two fields:
1. The patent term end date shown in the USPTO/patent record (and any adjustments).
2. The “patent expires” date shown for Multaq in the FDA Orange Book for the specific NDA.
If you share one detail, I can pinpoint it
If you paste either:
- the Orange Book NDA number for Multaq you’re looking at, or
- the application/publication info shown on the patent record (effective filing date) for US 8,602,215,
I can compute/confirm the expected expiration date and explain how it fits with Multaq timing.
Sources: none (no provided records to cite).